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Introduction. Fibrogenesis markers, such as alpha-actin (AA), CD163 (macrophages),
and E-cadherin, have been studied as chronic kidney allograft injury (CAI) predictors, a
major cause of allograft failure.
Objective. Investigate the value of thesemarkers in predictingCAI and initiation of dialysis.
Materials and Methods. Retrospective analysis of 26 kidney allograft biopsies (from
22 patients with CAI) during 2 years, evaluating intensity and percentage of marked cells
on glomeruli and tubulointerstitial compartment. At the time of the biopsy, patients were
45.5  15.8 years and 4.2 years after transplant, and they had a mean glomerular filtration
rate (GFR) of 25.8  9.9 mL/min. From an average of 8.5 glomeruli per biopsy, there
was 25% sclerosis in 17 cases, 26% to 50% in 5, and >50% in 4. Interstitial fibrosis or
tubular atrophy affected 25% of cortical area in 14 cases, 26% to 50% in 8, and >50% in
2. Twelve patients started dialysis 5.8  4.7 years after transplant, with an average GFR
20.9 mL/min at the time of the biopsy.
Results. There was a higher intensity and percentage of CD163-marked cells in the
tubulointerstitial compartment in advanced interstitial fibrosis. We found an association
between intensity of AA in the tubulointerstitial compartment and initiation of dialysis
(P ¼ .003) and a negative correlation between intensity of E-cadherin loss and GFR
(r ¼ 0.56, P ¼ .012).
Conclusions. In our study, intensity of tubulointerstitial AA was shown to be a predictor
of initiation of dialysis, and E-cadherin loss intensity was associated to CAI progression.
However, prospective and larger studies are needed to evaluate the predictive value of
these markers.*Address correspondence to Joana Silva Costa, Centro Hos-
pitalar e Universitário de CoimbraeHospitais da Universidade de
Coimbra, Serviço de Nefrologia, Praceta Prof Mota Pinto, 3000-
075 Coimbra, Portugal. E-mail: joana.c.s.costa@gmail.comTHE KIDNEY responds to injuries (hemodynamic,immune, or metabolic) through adaptive changes that
may evolve toward either its own healing and functional
recovery or scarring with loss of the kidney function. Scar-
ring is characterized by the replacement of intrinsic renal
cells with fibrous tissue made of collagenous extracellular
matrix (ECM) [1]. This affects the glomeruli, tubules, and
interstitium and vessel.
Mesangial cells are located in the glomeruli and play a
central role in the process of healing or scarring. They can
differentiate into an embryonic phenotype and acquire
alpha-smooth muscle actin (AA), allowing them to prolif-
erate, to migrate, and to restore the glomerular structuralvier Inc. All rights reserved.
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For personal use only. No other uses without permission.integrity [1]. However, when uncontrolled mesangial pro-
liferation occurs, an excessive matrix results in the “scar.”
Some tubular cells respond to an acute injury through
necrosis or apoptosis, whereas dedifferentiation into an
embryonic phenotype and acquisition of AA allow surviving
cells to attempt restoring tubule integrity. Repeated or
sustained injury is likely to induce epithelial-mesenchymal0041-1345/17
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Dowtransition (EMT). During EMT, epithelial cells acquire
migratory properties of mesenchymal cells and transit into
the interstitium [2,3]. Loss of E-cadherin, a transmembrane
glycoprotein and a differentiated epithelium marker, results
in the epithelium disintegration and is an early event during
EMT. Loss of epithelial cells contributes to myofibroblast
formation and fibrosis [4].
Both glomerulosclerosis and tubulointerstitial fibrosis are
stimulated by cytokines and growth factors. Transforming
growth factor b1 (TGF-b1) is the most important growth
factor inducing fibrosis [5]. Infiltration of the glomeruli and
renal interstitium with inflammatory cells is also a common
pathway in the pathogenesis of glomerulosclerosis and
tubulointerstitial fibrosis. If chronic injury and inflammation
persist, both M1 and M2 macrophages phenotypes can be
found. M1 macrophages are the first to be recruited for
removal of dead cells, but they can also exacerbate renal cell
damage by means of their proinflammatory action [2,6].
Furthermore, M2 phenotypes are anti-inflammatory mac-
rophages that can promote not only epithelial and vascular
repair but also fibrosis [5,6]. Specific M2 macrophage
markers CD163, CD206, and CD301 can be used to
differentiate them through flow cytometry. Macrophage
infiltration and local proliferation are related to the severity
of glomerular and tubulointerstitial damages and serve as
prognostic marker of disease progression [6]. Furthermore,
proliferative macrophages and AA and myofibroblast infil-
tration in areas of severe renal damage suggest an associa-
tion between macrophages and renal fibrosis in chronic
kidney disease progression [6].
Concerning kidney transplants, one study concluded that
AA expression in time-zero biopsies, especially its combi-
nation with interstitial fibrosis, could strongly predict
chronic renal allograft injury (CAI) [7]. TGF-b1 has been
suggested as the centric hypothesis for chronic allograft
rejection and CAI. Both immune (acute allograft rejection)
and nonimmune factors (calcineurin inhibitors [CNIs],
infection, ischemia, chronic hypertension, and others) can
be responsible for the allograft damage, and the intrarenal
overexpression of TGF-b1 can promote a progressive
damage [8,9]. However, TGF-b1 is also a potent immuno-
suppressant in the kidney allograft. The use of TGF-b1 as a
selective blockage (blocking the fibrogenic arm but not the
immunoregulatory arm) may be of benefit in minimizing the
allograft’s damage, but it remains a challenge [9].
It may be useful to understand fibrogenesis mechanisms
and identify CAI predictors to its early diagnosis. We have
designed this study to investigate the value of AA and
CD163 expression as well as the E-cadherin loss in pre-
dicting CAI and initiation of dialysis.MATERIALS AND METHODS
Population
We retrospectively analyzed 26 kidney allograft biopsies from
22 patients with CAI whose transplantations were performed
between January 2014 and December 2015. The 22 patientsnloaded for Anonymous User (n/a) at CONSORTIUM OF PORTUGAL-Centro Hosp
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the rest deceased donor recipients. At the time of biopsy, their
mean age was 45.5  15.8 years (minimum 19 years, maximum
72 years). All patients were medicated with corticoids, 21 patients
with CNIs, 20 patient with antimetabolite drugs, and 2 patients with
mammalian target of rapamycin inhibitors. They presented an
average of 4.2 years after transplant (minimum 4 years, maximum
18 years), and their mean glomerular filtration rate (GFR) was 25.8
 9.9 mL/min (7 patients with GFR 30e60 mL/min, 12 patients with
GFR 15e29 mL/min, and 3 patients with GFR <15 mL/min).
Twelve patients started dialysis 5.8  4.7 years after transplant. In
association with the diagnosis of CAI, 8 patients had acute T-cell-
mediated rejection (IA in 6 cases and IB in 2 cases), 11 patients had
borderline changes, and 5 patients had histologic findings suggesting
CNI toxicity.
From the previous report of the analyzed biopsy, with an average
of 8.5 glomeruli per biopsy, glomerulosclerosis was detected
in 25% of the glomeruli in 17 cases, 26% to 50% in 5 cases, and
>50% in 4 cases. At biopsy re-evaluation, 5 cases did not have
glomeruli. There were 2 cases of polyomavirus nephropathy with
interstitial fibrosis. Interstitial fibrosis or tubular atrophy
affected 25% of cortical area in 14 cases, 26% to 50% in 8, and
>50% in 2 cases.
Evaluation of Marked Cell
Using normal kidney tissue from a nephrectomized patient with a
localized tumor as control, 2 pathologists evaluated the intensity and
the percentage of marked cells (AA and CD163) in glomeruli,
tubules, and interstitium and the loss of E-cadherin in the tubules.
The final result was based on agreement or averaging of their results.
The intensity of marked cell or loss of E-cadherin was established
between1 (lowpositive) and3þ (highpositive), and thepercentageof
marked cell or loss of E-cadherin was defined from 0 to 100%.
Statistical Analysis
Spearman correlation coefficient was used to assess the relationship
between AA, CD163, and E-cadherin loss intensity and percentage
with CAI. c2 and Wilcoxon tests were used to assess the relation-
ship between these markers’ intensity and percentage, respectively,
with dialysis. The value of the markers to predict CAI and the
initiation of dialysis were determined by calculating the area under
the receiver operating characteristic curve (AUCROC). Because
CAI was classified in more than 2 groups, we used the multiclass
AUCROC as defined by Hand and Till [10]. The optimal cutoff
values for intensity and percentage of each marker were defined
using the Youden Index [11], which maximizes the sensitivity and
specificity of the predictor. Negative predictive values (NPVs) and
positive predictive values (PPVs) were calculated for each group of
CAI and also for the “initiation of dialysis.” All analysis was
conducted at an overall significance level of 5%. All statistical
analysis was conducted using R Statistical Software version 3.2.5.
RESULTS
In the glomeruli, a higher intensity of AA (mean 1.8) was
detected when glomerulosclerosis was between 26% and
50% (vs glomerulosclerosis 25%, with an AA mean in-
tensity of 1.6, and vs glomerulosclerosis >50%, with an AA
mean intensity of 1.0; Fig 1A). Cases without glomeruli at
biopsy re-evaluation (3 cases in the group of patients with
glomerulosclerosis 25% and 2 cases in the group ofitalar e Universitário de Coimbra from ClinicalKey.com by Elsevier on June 08, 2018.
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Fig 1. Biomarkers expression in the glomerulus and tubulointerstitial compartment. Alpha-smooth muscle actinemarked cells (400)
(A) and CD163-marked cells (200) (B); E-cadherin loss in more than 50% of the tubules (200) (C).
Table 2. AA, CD163, and E-Cadherin Loss Intensity/Percentage
Association With Chronic Allograft Dysfunction and Initiation of
Dialysis








Intensity 0.61 0.40 (0.104) .377
Percentage (%) 0.13 0.32 (0.191) .785
AA TI
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Dowpatients with glomerulosclerosis >50%) were excluded.
The same pattern occurred with CD163, where a higher
intensity (mean 2.8) was found in the group of patients
with glomerulosclerosis between 26% and 50% (vs
glomerulosclerosis 25%, with a CD163 mean intensity of
2.7, and vs glomerulosclerosis >50%, with a CD163 mean
intensity of 2.0; Fig 1B). The percentage of AA increased as
glomerulosclerosis occupied less glomerulus area. Counter
to what was expected, the results did not reveal a higher
percentage of AA- or CD163-marked cells in the cases with
higher glomerulosclerosis.
In the tubulointerstitial compartment, the intensity or
percentage of AA-marked cells was not higher in advanced
interstitial fibrosis (60.0% for interstitial fibrosis 25%
group and 35.0% for interstitial fibrosis >50% group), also
counter to what was expected. A higher CD163 intensity
(mean 3.0) and percentage of marked cells (mean 30.0%)
were detected in advanced interstitial fibrosis (vs interstitial
fibrosis 25%, with a CD163 mean intensity of 2.5 and a
percentage of marked cell of 17.1%, and interstitial fibrosis
between 26% and 50%, with a CD163 mean intensity of 2.5
and a percentage of marked cell of 24.4%). A higher in-
tensity or percentage of E-cadherin loss in advanced inter-
stitial fibrosis was not detected (55.0% for interstitial
fibrosis 25% group and 40.0% for interstitial fibrosis
>50% group; Fig 1C).
Furthermore, although the results expressed in Table 1
suggested a high CD163 and E-cadherin loss intensity andTable 1. Intensity and Percentage of Marked Cells According to
GFR at Biopsy Re-evaluation
GFR at the Time of Biopsy (mL/min)
<15 (3 Patients) 15e29 (12 Patients) 30e60 (7 Patients)
AA
Glomeruli 1þ (8.3%) 2þ (13.0%) 2þ (14.0%)
TI 2þ (19.5%) 2þ (32.0%) 2þ (32.5%)
CD163
Glomeruli 3þ (10.0%) 3þ (5.9%) 3þ (5.6%)
TI 3þ (20.0%) 3þ (20.2%) 3þ (14.3%)
E-cadherin loss 2þ (60.0%) 1þ (47.1%) 1þ (56.4%)
Abbreviations: AA, alpha-smooth muscle actin; GFR, glomerular filtration rate;
TI, tubulointerstitial compartment.
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statistically significant negative correlation between the
intensity of the E-cadherin loss and the GFR (r ¼ 0.56,
P ¼ .012; Table 2). A value of E-cadherin loss intensity
equal or greater than 2 was obtained as cutoff for CAI
group GFR <15 mL/min (NPV 0.95, PPV 1.0). The cutoff
value for intensity of E-cadherin loss obtained for the other
CAI groups was 1, which achieved in both cases a NPV of 1
and a PPV of 0.5 for GFR between 15 and 29 mL/min and
0.32 for GFR between 30 and 60 mL/min.
There were small differences in intensity and percentage
of marked cells between the group that started dialysis and
the group that did not start dialysis (Table 3). However, we
identified a statistically significant association between the
intensity of AA in the tubulointerstitial compartment and
the initiation of dialysis (P ¼ .003; Table 2). A value of AA
intensity in the tubulointerstitial compartment equal orIntensity 0.84 0.37 (0.086) .003†
Percentage (%) 0.23 0.20 (0.363) .506
CD163 glomeruli
Intensity 0.24 0.13 (0.617) .056
Percentage (%) 0.53 0.25 (0.326) .358
CD163 TI
Intensity 1 0.29 (0.194) >.999
Percentage (%) 0.26 0.26 (0.246) >.999
E-cadherin loss
Intensity 1 0.56 (0.012)† NE
Percentage (%) 0.04 0.04 (0.852) .415
Abbreviations: AA, alpha-smooth muscle actin; NE, not estimable; TI,
tubulointerstitial compartment.
*Intensity was assessed by c2 test, and percentage was assessed by
Wilcoxon test.
†Significant at the 5% alpha level.
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Table 3. Intensity and Percentage of Marked Cells in the Group
of Patients Who Started Dialysis and in the Group of Patients
Who Did Not Start Dialysis After Kidney Allograft Biopsy
Dialysis
Patients (n ¼ 12)
Nondialysis
Patients (n ¼ 10)
AA
Glomeruli 2þ (13.0%) 1þ (12.0%)
TI 2þ (23.5%) 1þ (25.0%)
CD163
Glomeruli 3þ (4.1%) 2þ (6.6%)
TI 3þ (17.0%) 3þ (20.0%)
E-cadherin loss 2þ (49%) 2þ (55%)
Abbreviations:AA, alpha-smoothmuscle actin; TI, tubulointerstitial compartment.
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Dowgreater than 2 of was obtained as cutoff for initiation of
dialysis (NPV 0.82, PPV 0.92).
Due to the small number of patients, all the computed 95%
confidence intervals for the AUCROC to assess the overall
performance of eachmarker in predicting CAI were too wide
to have informative value for the analysis. The AUCROC
values varied between 0.409 and 0.722 for the predictors of
CAI and between 0.396 and 0.867 for the predictors of initi-
ation of dialysis. The AUCROC value for the intensity of the
E-cadherin loss in predicting CAI was 0.722, and the
AUCROC value for the intensity of AA in the tubulointer-
stitial compartment in predicting the initiation of dialysis was
0.867 (95% confidence interval, 0.719e1.0; Fig 2).
DISCUSSION
In the last 20 years, the literature published onnewfibrogenesis
markers and their effect on the kidney disease progression has
been increasing. This has contributed to a better understandingFig 2. Receiver operating characteristic curve for the
intensity of alpha-smooth muscle actin in the tubulointerstitial
compartment in predicting the initiation of dialysis. Abbreviation:
CI, confidence interval.
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Consequently, the investigation of therapeutic targets has also
improved. One of these targets is the bone morphogenetic
protein-7, which is expressed in the developing kidney in
embryos as well as in the mature organ of adults, determining
the final number of nephrons [12]. Experimental animal
models have suggested that treatment with bone morphoge-
netic protein-7, a natural TGF-b1 antagonist, can protect from
fibrosis progression and even accelerate the return of renal
function [13]. Also rapamycin and sirolimus were reported to
have a significant potential for attenuating tubulointerstitial
damage in ratmodels andmaydelay theprogressionofCAI [5].
Other targets have been studied such as Akt2 (with a critical
role in mediating EMT) inhibition and administration of the
antifibrotic hepatocyte growth factor, mostly in animal trials
[4,14]. As far as we are aware of, no clinical effects of the
studied markers have yet been found.
In this retrospective study, 3 of the most discussed
markers of fibrosis were evaluated in kidney allograft
biopsies from patients with CAI: the AA (a myofibroblast
marker), the CD163 (a macrophage marker), and the loss of
E-cadherin (a differentiated epithelium marker).
Evaluation of the intensity and percentage of AA- and
CD163-marked cells or loss of E-cadherin, as fibrosis in-
creases in the different compartments, have led to incon-
clusive results. An exception can be made in reference to
the CD163 in the tubulointerstitial compartment, with a
higher intensity and percentage of marked cells detected in
the advanced interstitial fibrosis.
This study had some limitations such as the low number of
biopsies and the observer-dependent evaluation of intensity
and percentage ofmarked cell andE-cadherin loss. The fewer
glomeruli present at the time of the biopsy re-evaluation
could also have been a limitation to this study. Despite
these limitations, this study showed a statistically significant
prediction capacity of intensity of AA in the tubulointerstitial
compartment for initiation of dialysis. The cutoff obtained
(values of intensity equal or greater than 2) showed high
predictive ability for initiation of dialysis according to the
high NPV and PPV. We also found a statistically significant
correlation between E-cadherin loss intensity and CAI. The
cutoff for intensity of E-cadherin loss, as a predictor of CAI,
presented high predictive value for the group of patients with
GFR <15 mL/min, contrary to the findings in the other
groups. Thisfinding suggests that thismarkermay be useful as
a predictor for this specificCAI group and, therefore, for CAI
progression. Prospective and larger studies are needed to
evaluate the predictive value of these markers.REFERENCES
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